Cargando…
SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
BACKGROUND: The poor prognosis of patients with ovarian cancer is mainly due to cancer progression. γ-Synuclein (SNCG) has reported as a critical player in cancer metastasis. However, its biological roles and mechanism are yet incompletely understood in ovarian cancer, especially in high-grade serou...
Autores principales: | Zhang, Jing, Liu, Xiao-han, Li, Cong, Wu, Xiao-xing, Chen, Yan-lin, Li, Wen-wen, Li, Xian, Gong, Fan, Tang, Qin, Jiang, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204046/ https://www.ncbi.nlm.nih.gov/pubmed/32381034 http://dx.doi.org/10.1186/s13046-020-01589-9 |
Ejemplares similares
-
Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
por: Zhang, Jing, et al.
Publicado: (2020) -
Inhibition of SNCG suppresses the proliferation of lung cancer cells induced by high glucose
por: Fei, Jing, et al.
Publicado: (2021) -
Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease
por: Strohl, Anna, et al.
Publicado: (2016) -
Identification and validation of anoikis-associated gene SNCG as a prognostic biomarker in gastric cancer
por: Li, Yi, et al.
Publicado: (2023) -
Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway
por: Zhao, Kai-Hong, et al.
Publicado: (2017)